-
NCTN: A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) With or Without Cetuximab (C225) After Curative Resection for Patients With Stage III Colon Cancer (N0147)
Study
phs004241
-
Sequencing Data from Patient-Derived Models of Pediatric Cancer
Study
phs004719
-
Cancer Associated Fibroblasts Drive Epithelial to Mesenchymal Transition and Classical to Basal Change in Pancreatic Cancer Cells with Loss of IL-8 Expression
Study
phs004499
-
Childhood Cancer Data Initiative (CCDI): CCDI Pediatric In Vivo Testing Program - Orthotopic CNS Tumors
Study
phs003162
-
Radiology Imaging Data Containing Faces from The Cancer Imaging Archive
Study
phs004225
-
Impact of HLA Aberrations on Tumor Neoepitope Presentation
Study
phs004529
-
NCTN_NCORP: Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer (S0230)
Study
phs004261
-
Healthy Communities Study (HCS-BioLINCC)
Study
phs004494
-
Cellular and Molecular Profiling of Epithelial Ovarian Cancers and Associated Normal Tissues
Study
phs004702
-
Kids First: Genomics of Isolated Cleft Lip
Study
phs003893
-
Blood and Marrow Clinical Trials Network Trial of Non-Myeloablative Conditioning and Transplantation of Umbilical Cord Blood For Hematologic Malignancies (BMT CTN-0604-BioLINCC)
Study
phs004890
-
Cardiovascular Cell Therapy Research Network - A Phase I, First-in-Human, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Cancer Survivors With Anthracycline-Induced Cardiomyopathy (CCTRN-SENECA-BioLINCC)
Study
phs004712
-
BTC GBM TeamLab Trial 1: Longitudinal Tissue Profiling of Recurrent Malignant Glioma During Repeat Dosing of Oncolytic Viral Immunotherapy (NCT03152318)
Study
phs004189
-
NCTN: A Double Blind Randomization to Letrozole or Placebo for Women Previously Diagnosed with Primary Breast Cancer Completing Five Years of Adjuvant Aromatase Inhibitor either as Initial Therapy or after Tamoxifen (NCIC-MA.17R)
Study
phs004248
-
Dissecting the Role of the Microenvironment in Follicular Lymphoma Transformation
Study
phs004175
-
NCTN: Treatment of Atypical Teratoid/Rhabdoid Tumors (AT/RT) of the Central Nervous System with Surgery, Intensive Chemotherapy, and 3-D Conformal Radiation (ACNS0333)
Study
phs004137
-
Bulk ATAC and RNA Sequencing of Human Breast Cancer Metastasis Samples
Study
phs003363
-
CIDR: Understanding the Increased Risk of Childhood Acute Lymphoblastic Leukemia in Latinos
Study
phs003953
-
Testicular Cancer Consortium WES
Study
phs003107
-
Uncovering Colorectal Cancer Etiology and Biology by Integrating Proteomics with Other Omics Data
Study
phs004089
-
MP2PRT: Discovering Biomarkers of Outcome: EBV DNA Quantification and the Relationship of EBV and LINE1 Retrotransposon Expression in Pediatric Patients With Nasopharyngeal Carcinoma (NPC) Enrolled on ARAR0331
Study
phs003092
-
Reduction of Lethal Prostate Cancer Disparities in Underserved Hispanic/Latino Populations
Study
phs004487
-
Investigations of Genetic Variation in Families Affected by MUTYH-Associated Polyposis
Study
phs003554
-
HINTS Geo-Coded Data 2019 (HINTS 5 Cycle 3)
Study
phs004216
-
A Phase Ib Study of Sapacitabine and Olaparib in Patients With BRCA1/2-Mutated (BRCA1/2m) Metastatic Breast Cancer
Study
phs004095
-
Randomized Phase 2 Study of Neoadjuvant Chemotherapy, Carboplatin and Paclitaxel, with or without Atezolizumab in Triple Negative Breast Cancer (TNBC)
Study
phs003296
-
NCTN: Phase III Randomized Study of Sorafenib Plus Doxorubicin versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC) (CALGB-80802)
Study
phs004239
-
SMARCB1 Missense Mutants Destabilize SWI/SNF Complex Stability and Remodeling Activity
Study
phs003896
-
Whole Genome Sequencing of Locally Advanced Esophageal Cancer
Study
phs004613
-
Women's Health Initiative Clinical Trial and Observational Study-BioLINCC (WHI-BioLINCC )
Study
phs004266
-
Kids First: Childhood Cancer Data Initiative (CCDI) - Discovering the Timing and Origins of Bone and Soft Tissue Cancers
Study
phs002827
-
Utility of Pancreatic Tumor Scrapings for Organoid Development and Precision Medicine Strategies
Study
phs004385
-
Blood and Marrow Clinical Trials Network - Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN-0903-BioLINCC)
Study
phs004697
-
NCTN: A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children with Newly Diagnosed High Risk Hodgkin Lymphoma (AHOD0831)
Study
phs004161
-
NCTN: A Randomized Phase III Trial of CC-5013 (Lenalidomide) and Low Dose Dexamethasone (LLD) versus Bortezomib, Lenalidomide and Low Dose Dexamethasone (BLLD) for Induction, in Patients with Previously Untreated Multiple Myeloma (S0777)
Study
phs004247
-
Somatic Evolution in Li-Fraumeni Syndrome
Study
phs004484
-
Molecular Markers of Risk of Subsequent Invasive Breast Cancer in Women with Ductal Carcinoma in Situ
Study
phs004440
-
Women's Health Initiative (WHI) - Life and Longevity After Cancer (LILAC) (WHI-LILAC-BioLINCC)
Study
phs004174
-
Study of Novel Approaches for Prevention (SNAP-BioLINCC)
Study
phs004682
-
Blood and Marrow Transplant Clinical Trials Network - A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN-1703-BioLINCC)
Study
phs004711
-
Inherited Genetic Susceptibility in Langerhans Cell Histiocytosis
Study
phs004547
-
Personalized DNA and Peptide Vaccines Elicit Neoantigen-Driven T-Cell Responses in Pancreatic Cancer
Study
phs004463
-
Durvalumab and Cediranib with and without Olaparib in Recurrent Ovarian Cancer: A phase II Proof-of-Concept Study
Study
phs004519
-
PIGR+RORC+ Dendritic Cells (PRDCs) are an Immunomodulatory Subset Enriched in Malignant Ascites
Study
phs004309
-
NCTN: Dexamethasone Compared with Prednisone During Induction Therapy and Methotrexate with or without Leucovorin During Maintenance Therapy in Treating Patients with Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (AALL0232)
Study
phs004039
-
Global Health Centers of Excellence-New Delhi (GHCoE New Delhi-BioLINCC)
Study
phs004776
-
scRNA-seq of Multiple Myeloma and Tumor Microenvironment Cells from Bone Marrow During CAR T-Cell Therapy
Study
phs004878
-
Sequencing of Rare Pancreatic Tumors That Respond to PD-1 Blockade
Study
phs004257
-
Incidental Detection of Maternal Neoplasia through Non-Invasive Cell-Free DNA Analysis (IDENTIFY), a Natural History Study
Study
phs004107
-
Cetuximab and Nivolumab in Recurrent/Metastatic Head and Neck Cancer
Study
phs004268
-
Chromatin Accessibility Profiling Identifies a Stem Cell-Like Subtype of Small Cell Lung Cancer with Poor Prognosis
Study
phs003983
-
Molecular Profiling of Head and Neck Squamous Cell Carcinomas
Study
phs004476
-
NCTN: Randomized Phase III Study of Maintenance Therapy With Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC (E5508)
Study
phs004240
-
NCTN: A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer (E5103)
Study
phs004244
-
Genetic Factors Associated with Anthracycline-Induced Cardiomyopathy (COG-ALTE03N1)
Study
phs003792
-
Cutaneous Squamous Cell Carcinoma: Integrating Germline and Somatic Alterations that Underlie Tumor Progression
Study
phs003681
-
Molecular Characterization of the Immunological Landscape in Human Brain Tumors
Study
phs004853
-
Pursuing Molecular Biomarkers to Guide Adjuvant Therapy for HPV+ Head and Neck Cancers After Transoral Robotic Surgery
Study
phs003889
-
Kids First: Genomic Analysis of Pediatric Rhabdomyosarcoma
Study
phs004306
-
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care (ICARE-BioLINCC)
Study
phs004679
-
GENomics of CAncer DisparitiEs (GENCADE)
Study
phs003731
-
GU16-257: Neoadjuvant Gemcitabine, Cisplatin, Plus Nivolumab in Patients with Muscle-Invasive Bladder Cancer with Selective Bladder Sparing
Study
phs003372
-
NCTN: A Phase III Randomized Study of Nivolumab Plus Ipilimumab versus Nivolumab for Previously Treated Patients with Stage IV Squamous Cell Lung Cancer and No Matching Biomarker (Lung-Map Sub-Study) (S1400I)
Study
phs004242
-
CDK2 Inhibition Demonstrates RB-Independent Efficacy in CDK4/6 Inhibitor-Resistant HR-Positive/HER2-Negative Breast Cancer
Study
phs004466
-
NCTN: EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study (S0931)
Study
phs004249
-
Targeting SS18-SSX Biology in Synovial Sarcomagenesis
Study
phs004771
-
HINTS Geo-Coded Data 2017 (HINTS 5 Cycle 1)
Study
phs004210
-
Clonal Hematopoiesis Dynamics and Evolutionary Fitness During Breast Cancer Treatment Impact Clinical Outcomes
Study
phs004283
-
NCTN_NCORP: The Men's Eating and Living (MEAL) Study: A Randomized Trial of Diet to Alter Disease Progression in Prostate Cancer Patients on Active Surveillance (CALGB-70807)
Study
phs004238
-
Childhood Cancer Data Initiative (CCDI): Frameshift Mutation Profiling of Constitutional Mismatch Repair Deficiency Syndrome Patients
Study
phs004017
-
Childhood Cancer Data Initiative (CCDI): Metastatic Osteosarcoma Spatial Profiling
Study
phs003975
-
Genomic Landscape and Preclinical Therapeutic Insights Developed from Xenograft, Organoid, and Cell Line Models in the NCI's Patient-Derived Models Repository
Study
phs003984
-
NCTN: Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients with Melanoma That Has Been Removed by Surgery (E4697)
Study
phs004396
-
MP2PRT: Genomic and Molecular Characterization of Biomarkers Associated With Self-Reported Race/Ethnicity in High-Risk Endometrial Cancers From NRG Oncology/GOG Protocol 210, Molecular Staging of Endometrial Cancer (NCT00340808)
Study
phs002965
-
Dendritic Cell Redundancy Enables Priming of Anti-Tumor CD4 T Cells in Pancreatic Cancer
Study
phs004508
-
NCTN: A Randomized Phase III Trial of Endocrine Therapy plus Entinostat/Placebo in Patients with Hormone Receptor-Positive Advanced Breast Cancer (E2112)
Study
phs004252
-
Proteogenomic Studies to Understand Mechanisms and Drivers of Resistance to Immunotherapies
Study
phs004511
-
Childhood Cancer Data Initiative (CCDI): Admixture Analysis of Acute Lymphoblastic Leukemia in African American Children: The ADMIRAL Study
Study
phs004222
-
Southern Community Cohort Study - the Gut Microbiome Project
Study
phs004716
-
Transcriptome of Human Merkel Cell Carcinoma
Study
phs003411
-
NCTN: ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma (E2805)
Study
phs004235
-
Subtyping of Small Cell Lung Cancer Using ChIP-Seq of Plasma Cell-Free Nucleosomes and Matched Tumor Transcriptomes
Study
phs003628
-
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis (ATTRACT-BioLINCC)
Study
phs004818
-
NCTN: The Treatment of Down Syndrome Children with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) under the Age of 4 Years (AAML0431)
Study
phs004144
-
Dietary Intervention Study in Children Follow-Up Study (DISC06-BioLINCC)
Study
phs004554
-
NCTN: Treatment of Children with All Stages of Hepatoblastoma with Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment (AHEP0731)
Study
phs004135
-
NCI's Collection of Datasets for Pediatric and Adolescent and Young Adults Research
Study
phs003964
-
NCTN: Phase III Trial of Tamoxifen Alone vs. Tamoxifen Plus Radiation Therapy for Good Risk Duct Carcinoma In-Situ (DCIS) of the Female Breast (RTOG-98-04)
Study
phs004264
-
Real-Time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine
Study
phs001652
-
Blood and Marrow Transplant Clinical Trials Network - Randomized Multicenter Trial Comparing Sirolimus Plus Prednisone and Sirolimus/Calcineurin Inhibitor Plus Prednisone for the Treatment of Chronic Graft-versus-Host Disease (BMT-CTN-0801-BioLINCC)
Study
phs004641
-
Field Effect-Informed Urine Liquid Biopsy Analysis for Assessment of Adjuvant BCG Response in Non-Muscle Invasive Bladder Cancer
Study
phs004110
-
NCTN: A Phase III Protocol of Androgen Suppression (AS) and 3DCRT/IMRT Vs AS and 3DCTR/IMRT Followed by Chemotherapy with Docetaxel and Prednisone for Localized, High-Risk, Prostate Cancer (RTOG-0521)
Study
phs004255
-
Whole-Exome Sequencing of Acute Myeloid Leukemia
Study
phs003966
-
NCTN: CHAARTED: ChemoHormonal Therapy Versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer (E3805)
Study
phs004201
-
HINTS Geo-Coded Data 2011 (HINTS 4 Cycle 1)
Study
phs004212
-
Spindle Assembly Checkpoint Competency Determines Sensitivity to KIF18A Inhibition in Small-Cell Lung Cancer
Study
phs004869
-
Germline EGFR T790M and Lung Cancer Risk
Study
phs004412
-
Proteogenomic Characterization of Human Uterine Cervical Cancer
Study
phs002916
-
NCTN: A Randomized Double-Blind, Placebo-Controlled Phase III Study of Early versus Standard Zoledronic Acid to Prevent Skeletal Related Events in Men with Prostate Cancer Metastatic to Bone (CALGB-90202)
Study
phs004392
-
Environmental Chemical Body Burden and Prospective Breast Cancer Risk in the Cancer Prevention Study-3 Cohort - CIDR
Study
phs003494